April 30, 2018 / 11:53 AM / 21 days ago

BRIEF-Spark Therapeutics Says Entered Into Asset Purchase Agreement With Jazz Pharmaceuticals Ireland Ltd

April 30 (Reuters) - Spark Therapeutics Inc:

* SPARK THERAPEUTICS SAYS ENTERED INTO ASSET PURCHASE AGREEMENT WITH JAZZ PHARMACEUTICALS IRELAND LIMITED - SEC FILING

* SPARK THERAPEUTICS - PURSUANT TO AGREEMENT CO AGREED TO SELL RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER

* SPARK THERAPEUTICS - JAZZ WILL PAY CO $110 MILLION FOR PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER UPON CLOSING OF PURCHASE - SEC FILING Source text: [bit.ly/2HCWVjZ] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below